Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Quality of Life Research
Published in: Quality of Life Research 10/2010

Open Access 01-12-2010

Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes

Authors: Mirjam A. G. Sprangers, Jeff A. Sloan, Andrea Barsevick, Cynthia Chauhan, Amylou C. Dueck, Hein Raat, Quiling Shi, Cornelis J. F. Van Noorden, The GENEQOL Consortium

Published in: Quality of Life Research | Issue 10/2010

Login to get access

Abstract

Objectives

There is emerging evidence for a genetic basis of patient-reported quality-of-life (QOL) outcomes that can ultimately be incorporated into clinical research and practice. Objectives are (1) to provide arguments for the timeliness of investigating the genetic basis of QOL given the scientific advances in genetics and patient-reported QOL research; (2) to describe the clinical implications of such investigations; (3) to present a theoretical foundation for investigating the genetic underpinnings of QOL; and (4) to describe a series of papers resulting from the GENEQOL Consortium that was established to move this work forward.

Methods

Discussion of scientific advances based on relevant literature.

Results

In genetics, technological advances allow for increases in speed and efficiency and decreases in costs in exploring the genetic underpinnings of disease processes, drug metabolism, treatment response, and survival. In patient-based research, advances yield empirically based and stringent approaches to measurement that are scientifically robust. Insights into the genetic basis of QOL will ultimately allow early identification of patients susceptible to QOL deficits and to target care. The Wilson and Cleary model for patient-reported outcomes was refined by incorporating the genetic underpinnings of QOL.

Conclusions

This series of papers provides a path for QOL and genetics researchers to work together to move this field forward and to unravel the intricate interplay of the genetic underpinnings of patient-reported QOL outcomes. The ultimate result will be a greater understanding of the process relating disease, patient, and doctor that will have the potential to lead to improved survival, QOL, and health services delivery.
Appendix
Available only for authorised users
Literature
1.
Hardy, J., & Singleton, A. (2009). Genomewide association studies and human disease. New England Journal of Medicine, 360, 1759–1768.CrossRefPubMed
2.
Hirschhorn, J. N. (2009). Genomewide association studies—Illuminating biologic pathways. New England Journal of Medicine, 360, 1699–1701.CrossRefPubMed
3.
Seabrook, J. A., & Avison, W. R. (2010). Genotype-environment interaction and sociology: Contributions and complexities. Social Science and Medicine, 70, 1277–1284.CrossRefPubMed
4.
Patrick, D. L., Burke, L. B., Powers, J. H., Scott, J. A., Rock, E. P., Dawisha, S., et al. (2007). Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health, 10, S125–S137.CrossRefPubMed
5.
Hahn, E. A., Cella, D., Chassany, O., Fairclough, D. L., Wong, G. Y., Hays, R. D., et al. (2007). Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clinic Proceedings, 82, 1244–1254.CrossRefPubMed
6.
Hüebner, C., Petermann, I., Browning, B. L., Shelling, A. N., & Ferguson, L. R. (2007). Triallelic single nucleotide polymorphisms and genotyping error in genetic epidemiology studies: MDR1 (ABCB1) G2677/T/A as an example. Cancer Epidemiology, Biomarkers and Prevention, 16, 1185.CrossRefPubMed
7.
Pluzhnikov, A., Below, J. E., Konkashbaev, A., Tikhomirov, A., Kistner-Griffin, E., Roe, C. A., et al. (2010). Spoiling the whole bunch: Quality control aimed at preserving the integrity of high-throughput genotyping. The American Journal of Human Genetics, 87, 123–128.CrossRef
8.
Fayers, P. M., Hopwood, P., Harvey, A., Girling, D. J., Machin, D., & Stephens, R. (1997). Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: The UK Medical Research Council experience. MRC Cancer Trials Office. European Journal of Cancer, 33, 20–28.CrossRefPubMed
9.
De Haes, J., Curran, D., Young, T., Bottomley, A., Flechtner, H., Aaronson, N., et al. (2000). Quality of life evaluation in oncological clinical trials—the EORTC model. European Journal of Cancer, 36, 821–825.CrossRefPubMed
10.
Bottomley, A., Jones, D., & Claassens, L. (2009). Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European Journal of Cancer, 45, 347–353.CrossRefPubMed
11.
Efficace, F., Bottomley, A., Osoba, D., Gotay, C., Flechtner, H., D’haese, S., et al. (2003). Beyond the development of health-related quality of life (HRQOL) measures. A checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision-making? Journal of Clinical Oncology, 21, 3502–3511.CrossRefPubMed
12.
Efficace, F., Osoba, D., Gotay, C., Sprangers, M., Coens, C., & Bottomley, A. (2007). Has the health-related quality of life reporting in clinical cancer trials improved over time? Towards bridging the gap with clinical decision making. Annals of Oncology, 18, 775–781.CrossRefPubMed
13.
Idler, E. L., & Benyamini, Y. (1997). Self-rated health and mortality: A review of 27 community studies. Journal of Health and Social Behavior, 38, 21–37.CrossRefPubMed
14.
Singh, J. A., Nelson, D. B., Fink, H. A., & Nichol, K. L. (2005). Health-related quality of life predicts future health-care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: The veterans arthritis quality of life study. Seminars in Arthritis Rheumatism, 34, 755–765.CrossRefPubMed
15.
Cunningham, W. E., Crystal, S., Bozzette, S., & Hays, R. D. (2005). The association of health-related quality of life with survival among persons with HIV infection in the United States. Journal of General Internal Medicine, 20, 21–27.CrossRefPubMed
16.
Mapes, D. L., Lopes, A. A., Satayathum, S., Mccullough, K. P., Goodkin, D. A., Locatelli, F., et al. (2003). Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney International, 64, 339–349.CrossRefPubMed
17.
Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology, 26, 1355–1363.CrossRefPubMed
18.
Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61, 102–109.CrossRefPubMed
19.
Norman, G. R., Wyrwich, K. W., & Patrick, D. W. (2007). The mathematical relationship among different forms of responsiveness coefficients. Quality of Life Research, 16, 815–822.CrossRefPubMed
20.
Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56, 395–407.CrossRefPubMed
21.
Sprangers, M. A. G. (2010). Disregarding clinical trial-based patient-reported outcomes is unwarranted: Five advances to substantiate the scientific stringency of quality-of-life measurement. Acta Oncologica, 49, 155–163.CrossRefPubMed
22.
Nes, R. B., Røysamb, E., Tambs, K., Harris, J. R., & Reichborn-Kjennerud, T. (2006). Subjective well-being: Genetic and environmental contributions to stability and change. Psychological Medicine, 36, 1033–1042.CrossRefPubMed
23.
Svedberg, P., Gatz, M., Lichtenstein, P., Sandin, S., & Pedersen, N. L. (2005). Self-rated health in a longitudinal perspective: A 9-year follow-up twin study. Journal of Gerontology Series B: Psychological Sciences and Social Sciences, 60, S331–S340.
24.
Romeis, J. C., Heath, A. C., Xian, H., Eisen, S. A., Scherrer, J. F., Pedersen, N. L., et al. (2005). Heritability of SF-36 among middle-age, middle-class, male-male twins. Medical Care, 43, 1147–1154.CrossRefPubMed
25.
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., et al. (2000). Environmental and heritable factors in the causation of cancer. The New England Journal of Medicine, 343, 78–85.CrossRefPubMed
26.
Sloan, J., & Zhao, X. (2006). Genetics and quality of life. Current Problems in Cancer, 30, 255–260.CrossRefPubMed
27.
Yang, P., Mandrekar, S. J., Hillman, S. H., Allen Ziegler, K. L., Sun, Z., Wampfler, J. A., et al. (2009). Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: An NCCTG-97-24-51 based study. Journal of Thoracic Oncology, 4, 479–485.CrossRefPubMed
28.
Janssens, A. C., & Van Duijn, C. M. (2009). Genome-based prediction of common diseases: Methodological considerations for future research. Genome Medicine, 18, 20.CrossRef
29.
Ioannidis, J. P. A. (2010). Genetics, personalized medicine, and clinical epidemiology: Expectations, validity, and reality in omics. Journal of Clinical Epidemiology, 63, 945–949.CrossRefPubMed
30.
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Journal of the American Medical Association, 273, 59–65.CrossRefPubMed
31.
de la Fuente-Fernandez, R. (2009). The placebo-reward hypothesis: Dopamine and the placebo effect. Parkinsonism and Related Disorders, 15S3, S72–S74.CrossRef
32.
Campbell, C. M., & Edwards, R. R. (2009). Mind-body interactions in pain: The neurophysiology of anxious and catatstrophic pain-related thoughts. Translational Research, 153, 97–101.CrossRefPubMed
33.
Higgins, E. S. (2009). The new genetics of mental illness. Scientific American Mind, 19, 41–47.
34.
Halfon, N., & Hochstein, M. (2002). Life course health development: An integrated framework for developing health, policy, and research. The Milbank Quarterly, 80, 433–479.CrossRefPubMed
35.
Sprangers, M. A. G., Sloan, J. A., Veenhoven, R., Cleeland, C. S., Halyard, M. Y., Abernethy, A. P., et al. (2009). The establishment of the GENEQOL Consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Research Human Genetics, 12, 301–311.CrossRef
36.
Chauhan, C. I am the quintessential optimist, I think that I have the quality-of-life gene in spades: reflections from a patient perspective (Commentary). Quality of Life Research, Epub ahead of print.
37.
Shi, Q., Cleeland, C., Miaskowski, C., Klepstad, P., Pedersen, N., & The GENEQOL Consortium. Biological pathways and genetic variables involved in pain. Quality of Life Research, manuscript accepted for publication.
38.
Barsevick, A., Frost, M., Zwinderman, A., Hall, P., Halyard, M. I., & The GENEQOL Consortium. I am so tired: Biological and genetic mechanisms of cancer-related fatigue. Quality of Life Research, manuscript accepted for publication.
39.
Sprangers, M. A. G., Bartels, M., Veenhoven, R., Baas, F., Martin, N., Movsas, B., et al. Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Quality of Life Research, Epub ahead of print.
40.
Raat, H., Van Rossem, L., Jaddoe, V. W. V., Landgraf, J. M., Feeny, D., Hofman, A., & Mackenbach, J. P. Candidate gene study and genome-wide association study on health-related quality of life of mothers and young children: the Generation R study. Quality of Life Research, manuscript accepted for publication.
41.
Attia, J., Ionannidis, J. P. A., Thakkinstian, A., McEvoy, M., Scott, R. J., Minelli, C., et al. (2009). How to use an article about genetic association A: Backgound concepts. Journal of the American Medical Association, 301, 74–81.CrossRefPubMed
42.
Plomin, R., DeFries, J. C., McClearn, G. E., & McGuffin, P. (2008). Behavioral genetics (5th ed., pp. 1–532). New York: Worth Publishers and W. H. Freeman and Company.
43.
Hardy, J., & Singleton, A. (2009). Genomewide association studies and human disease. The New England Journal of Medicine, 360, 1759–1768.CrossRefPubMed
Metadata
Title
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes
Authors
Mirjam A. G. Sprangers
Jeff A. Sloan
Andrea Barsevick
Cynthia Chauhan
Amylou C. Dueck
Hein Raat
Quiling Shi
Cornelis J. F. Van Noorden
The GENEQOL Consortium
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Quality of Life Research / Issue 10/2010
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9759-5

Other articles of this Issue 10/2010

Quality of Life Research 10/2010 Go to the issue

OriginalPaper

Valuing health in a racially and ethnically diverse community sample: an analysis using the valuation metrics of money and time

BriefCommunication

Reliability and validity of the Iranian version of the Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in adolescents

OriginalPaper

New model to explain the EQ-5D VAS in patients who have undergone spinal fusion

OriginalPaper

I’m so tired: biological and genetic mechanisms of cancer-related fatigue

OriginalPaper

Biological pathways and genetic variables involved in pain

OriginalPaper

Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states